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Twelve consecutive carbapenem-resistant Escherichia coli isolates were recovered from patients (infection or colonization) hos-
pitalized between March and September 2012 in different units at a hospital in Bulgaria. They all produced the carbapenemase
NDM-1 and the extended-spectrum--lactamase CTX-M-15, together with the 16S rRNA methylase RmtB, conferring high-level
resistance to all aminoglycosides. All those isolates were clonally related and belonged to the same sequence type, ST101. In addi-
tion to being the ﬁrst to identify NDM-producing isolates in Bulgaria, this is the very ﬁrst study reporting an outbreak of NDM-
1-producing E. coli in the world.
Worldwide occurrence of carbapenemase producers amongEnterobacteriaceae is now well recognized (1, 2). In Europe,
there are distinct epidemiological situations corresponding
mainly to the diffusion of OXA-48 producers in France, Belgium,
The Netherlands, and Turkey (3, 4) and KPC-producing isolates
in Italy and Greece (5), while some countries show more diverse
distributions, such as in the United Kingdom, where KPC, OXA-
48, VIM, and NDM-1 producers are being found (6). The recent
emergence of NDM-1 producers (mostly Klebsiella pneumoniae
isolates) is often related to imported cases, with a link to the Indian
subcontinent (7). In addition, there are sporadic reports of
NDM-1 producers (Enterobacteriaceae, Acinetobacter baumannii,
and Pseudomonas aeruginosa) originating from countries of the
Middle East or the Balkan region, including Croatia, Kosovo, and
Serbia (7, 8). Very little information is available regarding the
diffusion of carbapenemase producers in Eastern Europe.
Therefore, our study aimed to characterize the mechanisms
responsible for carbapenem resistance by investigating a collec-
tion of enterobacterial isolates recovered in Bulgaria. From March
to September 2012, 12 Escherichia coli isolates being resistant to
carbapenems were recovered at the Military Medical Academy
hospital of Soﬁa, Bulgaria. Susceptibility testing was performed by
disk diffusion on solid agar plates following the CLSI recommen-
dations (9). Those isolates had been recovered from urine (n 4),
blood (n  1), respiratory specimens (n  2), wound (n  1),
catheter (n  1), abdominal exudate (n  1), and rectal swabs
(n 2). The MICs of carbapenems were determined by Etest (AB
bioMérieux, La Balme-les-Grottes, France) on Mueller-Hinton
agar plates at 37°C, and results of susceptibility testing were inter-
preted according to the CLSI guidelines (10). The MICs of imi-
penem, meropenem, and ertapenem were 32, 32, and 32
g/ml for all theE. coli isolates, respectively. Theywere resistant to
all-lactams, including broad-spectrumcephalosporins (MICs of
ceftazidime and cefotaxime being32 g/ml) (Table 1). In addi-
tion, they were resistant to all tested aminoglycosides (amikacin,
gentamicin, netilmicin, kanamycin) and to ﬂuoroquinolones and
sulfonamides. Using the Etest, the MIC of rifampin was elevated
(128 g/ml), and that of colistin was found to be 0.5 g/ml.
Carbapenemase detection was performed by using the Carba
NP test (11), and positive results were obtained for all isolates.
PCR assays were performed to identify the type of carbapenemase
produced, with a series of primers designed for the detection of
blaKPC, blaIMP, blaVIM, blaNDM, and blaOXA-48 carbapenemase
genes (12). They revealed that all isolates were positive for a
blaNDM-like gene, and sequencing always identiﬁed blaNDM-1.
Then, double-disk synergy testing was performed as described
previously (10) and showed that all E. coli isolates produced an
extended-spectrum -lactamase (ESBL). PCR experiments per-
formed as described previously (13) followed by sequencing iden-
tiﬁed the blaCTX-M-15 gene in all isolates.
Considering the high-level resistance to all aminoglycosides
observed for all E. coli isolates, a search of 16S rRNA methylase-
encoding genes was performed by multiplex PCR as described
previously (14). Results showed that all isolates were positive for
the 16S rRNA methylase RmtB-encoding gene.
Genotyping was performed by pulsed-ﬁeld gel electrophoresis
as described previously (15) and showed indistinguishable pat-
terns among all the E. coli isolates (data not shown). This sug-
gested that the isolates had been recovered during an epidemic
context. Then, multilocus sequence typing was performed as de-
scribed (http://mlst.ucc.ie/mlst/dbs/Ecoli) and showed that this
clone belonged to sequence type 101 (ST101).
Interestingly, all the patients infected or colonized with that
clone had been hospitalized in different hospitalization units dur-
ing a short period of time (Table 1). The index case was not iden-
tiﬁed, and the source of that strain in the hospital setting could not
be determined. Of note, whereas there have been several reported
outbreaks involving NDM-1-producing K. pneumoniae in differ-
ent countries, such as Turkey (16, 17), Colombia (18), Canada
(19), Kenya (20), Italy (21), and South Korea (22), reports of
NDM-1-producingE. colihave been scattered (13, 23–26), includ-
ing isolates recovered from companion animals in the United
States (27). However, nosocomial transmissions of NDM-1-pro-
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ducing E. coli are extremely rare, with one recent report from
South Korea (28). Of note, that latter study also showed that an
ST101 E. coli clone was involved, even though the authors high-
lighted the poor standards of hygiene observed in the correspond-
ing hospital (28). As known for ESBL producers, outbreaks due to
multidrug-resistant Enterobacteriaceae are related mainly to the
diffusion of Klebsiella pneumoniae. It remains to determine
whether NDM-1-producing E. coli could eventually be wide-
spread in the community in the same geographical area, consti-
tuting a signiﬁcant reservoirwhich has been shown to often lead to
recurrent importations in the hospital settings (29).
Of note, we characterized here another enterobacterial strain co-
harboring blaNDM-1 together with a 16S rRNA methylase-encoding
gene, such association being extremely frequent, regardless of the
type of methylase gene (13, 30). However, this speciﬁc association
between the blaNDM-1 and rmtB genes has been very rarely reported,
andmainly inE. coli, with a single isolate from Australia (25) and a
single isolate from Belgium (Pakistan origin) (31).
In order to evaluate whether the cooccurrence of the blaNDM-1
and the rmtC genes could be related to the spread of a speciﬁc
plasmid,mating-out assayswere performedusing all those isolates
as donors and with E. coli J53 as the recipient, as described previ-
ously (25). Interestingly, E. coli transconjugants coproducing
NDM-1 and RmtC were obtained for all isolates, and a single
plasmid of ca. 150 kb was identiﬁed in all transconjugants. That
plasmid additionally conferred elevated MICs of rifampin to all
transconjugants (64 g/ml). However, it did not harbor the
blaCTX-M-15 gene, in accordance with the susceptibility to aztreo-
nam (a substrate spared by NDM-1) (32) observed for the E. coli
transconjugants. Attempts to type this plasmid by using the PCR-
based replicon typing (33) remained unsuccessful. PCR mapping
was performed to identify the genetic sequences surrounding the
blaNDM-1 gene in all positive isolates. The same structure was
found, with the blaNDM-1 gene preceded by a truncated version of
ISAba125, followed by the bleMBL gene encoding resistance to
bleomycin (34). Similar structures have been identiﬁed previously
in different species from different countries (7).
Our study further highlights the spread of the blaNDM-1 gene in
Balkan countries and also further highlights the accumulation of
resistance traits that may be found among most NDM-1 produc-
ers. This E. coli-related nosocomial outbreak is intriguing since E.
coli is rarely found as a source of nosocomial infections. Further
investigations will be performed in order to evaluate whether this
ST101 E. coli clonemight possess some speciﬁc features enhancing
its spread or persistence, knowing that ST101 NDM-1-producing
E. coli strains have been formerly reported in South Korea (28),
Canada (35), England (36), Pakistan (36), and India (37).
In addition, further investigations are now required to better
evaluate to what extent the blaNDM-1 gene might be disseminated
in Bulgaria. Interestingly, while this work was in progress, the ﬁrst
studies documenting the occurrence of carbapenemase-produc-
ing Enterobacteriaceae in that country have been published, in-
cluding VIM-1-producing K. pneumoniae and Proteus mirabilis
(38) and KPC-2-producing K. pneumoniae (39), thus suggesting a
heterogeneous distribution of those emerging resistance traits.
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TABLE 1 Features of the NDM-1- and RmtC-producing E. coli isolates and patient characteristicsa
Patient/strain
no.
Date of
isolation
(mo/day/yr)
Site of
isolation
Status of
the patient Gender
Hospitalization
unit Underlying disease Treatment Outcome
1 02/27/2012 Urine Infected F ICU-1 Pneumonia Ampicillin-sulbactam Died
2 02/27/2012 Urine Infected M ICU-1 Pneumonia Aztreonam Died
3 03/05/2012 Body ﬂuid Colonized F ICU-1 Unknown None Discharged
4 03/10/2012 ETA Colonized F ICU-1 Unknown None Discharged
5 03/14/2012 ETA Infected F ICU-1 Pancreatitis/septic
shock
Cefepime and amikacin Died
6 03/19/2012 Body ﬂuid Colonized M ICU-1 Unknown None Discharged
7 03/19/2012 Rectal swab Colonized M Hepatology Unknown None Discharged
8 03/19/2012 Urine Colonized M ICU-1 Unknown None Discharged
9 03/23/2012 Stool Infected M Hepatology Rectal ﬁstula Tigecycline Died
10 05/23/2012 Blood Infected M Gastroenterology Postcholecystectomy
sepsis
Meropenem Discharged
11 08/08/2012 Wound Colonized M Vascular surgery Unknown None Discharged
12 08/09/2012 Urine Colonized M ICU-2 Unknown None Discharged
a ETA; endotracheal aspirate; ICU; intensive care unit; M, male; F, female.
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